LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 62.39 | 21.74 | 1358 | 6112 | 0.2222 | 0.6624 | MN20160310_N01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 62.39 | 21.74 | 6452 | 6112 | 1.0555 | 1.0133 | MN20160310_N01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 62.39 | 21.74 | 6 | 6112 | 0.0010 | -0.1464 | MN20160310_N01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 62.39 | 21.74 | 7387 | 6112 | 1.2085 | 1.0471 | MN20160310_N01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 64.36 | 21.74 | 1444 | 6191 | 0.2332 | 0.6730 | MN20160310_N01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 64.36 | 21.74 | 6708 | 6191 | 1.0835 | 1.0198 | MN20160310_N01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 64.36 | 21.74 | 2 | 6191 | 0.0003 | -0.2537 | MN20160310_N01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 64.36 | 21.74 | 7703 | 6191 | 1.2442 | 1.0543 | MN20160310_N01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 66.33 | 21.74 | 1510 | 6235 | 0.2422 | 0.6811 | MN20160310_N01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 66.33 | 21.74 | 7146 | 6235 | 1.1460 | 1.0337 | MN20160310_N01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 66.33 | 21.74 | 3 | 6235 | 0.0005 | -0.2154 | MN20160310_N01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 66.33 | 21.74 | 8059 | 6235 | 1.2924 | 1.0638 | MN20160310_N01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 68.30 | 21.74 | 1705 | 6244 | 0.2730 | 0.7061 | MN20160310_N01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 68.30 | 21.74 | 7352 | 6244 | 1.1773 | 1.0404 | MN20160310_N01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 68.30 | 21.74 | 8 | 6244 | 0.0013 | -0.1152 | MN20160310_N01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 68.30 | 21.74 | 8325 | 6244 | 1.3331 | 1.0717 | MN20160310_N01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 70.27 | 21.74 | 1757 | 6201 | 0.2833 | 0.7135 | MN20160310_N01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 70.27 | 21.74 | 7852 | 6201 | 1.2661 | 1.0587 | MN20160310_N01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 70.27 | 21.74 | 4 | 6201 | 0.0006 | -0.1874 | MN20160310_N01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 70.27 | 21.74 | 8592 | 6201 | 1.3854 | 1.0816 | MN20160310_N01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 72.24 | 21.74 | 1790 | 6162 | 0.2905 | 0.7184 | MN20160310_N01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 72.24 | 21.74 | 8204 | 6162 | 1.3314 | 1.0715 | MN20160310_N01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 72.24 | 21.74 | 1 | 6162 | 0.0002 | -0.3147 | MN20160310_N01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 72.24 | 21.74 | 8916 | 6162 | 1.4469 | 1.0928 | MN20160310_N01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 74.21 | 21.74 | 1780 | 6235 | 0.2855 | 0.7153 | MN20160310_N01 | C22 |